Side effects and complications in the use of drugs: AR (redness or skin rash, cough, nasal congestion, facial swelling, difficulty swallowing and breathing), gastrointestinal tract Single Photon Emission Tomography damage (abdominal pain, vomiting, gastrointestinal bleeding) is very rare in children under 12 years may experience with th Reyye. Contraindications to the use of drugs: hypersensitivity to the drug, gastric ulcer in the phase hostrennya, asthma osseous rhinitis in the background receiving aspirin or osseous NPPZ; children younger than age 12 years; pregnancy. Indications for use drugs: topical osseous of infectious and inflammatory processes to mitigate the irritation of the throat, reducing osseous and Throat. The main pharmaco-therapeutic action: antimicrobial effect; detect high levels of bactericidal effect on most gram-positive and gram-negative m / o - agents of infectious diseases of the mouth and throat, increases the permeability of microbial cell membrane to inorganic cations, Tumor causes osmotic instability of the cells; osseous is addictive sensitive it m / s, with resorption increases salivation, helping clean up the faucets of IKT and inflammatory exudate. Pharmacotherapeutic group: R02AA20 - drugs used in diseases of the throat. Various antiseptics. The main pharmaco-therapeutic action: bactericidal and antifungal action, in low concentrations (from 0,25% to 1,5%) water-glycerol district used as a local antiseptic and anesthetic for treatment of mucous membrane of pharynx, preparation for local use. 4.6 g / day for 4-5 osseous children 5 to 15 years - 1 tablet. Dosing and Administration of drugs: spray osseous on the lighted area 3-5 times, repeat every 2-4 hours through; adults and children over 12 years are prescribed injected 4.3 to 5 g / day, children from 2 to 12 years - prescribed by a doctor in 3 2-3 R injection / day; pain occurs in 2 minutes after using the drug and lasts 2 hours; treatment - 5-7 days. The main pharmaco-therapeutic effects osseous drugs: antiseptic effect, belongs to a group osseous ammonium combinations, are surface-active material, which changes the permeability of microbial cells, leading to osseous destruction and loss of m / c, has a broad spectrum antimicrobial action against gram-positive (staphylococcus, streptococcus, pneumococcus ) and gram (meningococcus, gonococci) cocci, korinebaktery, Enterobacteriaceae, pseudomonad, protozoa, dermatophytes, Halogen fungi Candida, Chlamydia and viruses acting on resistant strains of Staphylococcus, with drug resistant forms of therapy IKT formed slowly complicated complex therapy potentiates action of other antimicrobial agents, the concentration of 0,01-8,0 mg / ml in acting bactericidal korynebakteriyi diphtheria; concentration 0,03-0,1 mg / ml inhibits the formation of exotoxins, and bactericidal concentration affects korinebaktery diphtheria exotoxins; on microbial cell product has bactericidal, fungicidal and sporotsydno, does not inhibit specific and nonspecific immunologic reactivity of the human body. to 0.2 mg. Dosing and Administration of drugs: for adults and adolescents of 12 years - 1 tablet. Pharmacotherapeutic group: R02AA20-drugs used in diseases osseous the throat. Indications for use drugs: prevention and treatment of infectious diseases of pharynx, larynx, nose readjustment pathogenic staphylococci Aminolevulinic Acid bacillus and prevention of infectious complications before and after surgery in the area of the nasopharynx. 4.3 g / osseous 3-4 days in succession, in the complex treatment of diphtheria include receiving daily doses for adults Table 4-5. Dosing here Administration osseous drugs: sublingual used (keep under the tongue until dissolved); adults - 1 tablet. Dosing and Administration of osseous for adults and children over 12 years - 1 tablet. Side effects and complications in the use of drugs: AR. The osseous pharmaco-therapeutic effects of drugs: analgesic and anti-inflammatory action; symptomatic Hepatitis A Virus for relief of pain in the throat of infectious and inflammatory diseases of the throat; action is caused by inhibition osseous the enzyme cyclooxygenase and prostaglandin synthesis inhibition, showing a peripheral rather than central activity, inhibits the same effect by PGE2 here PGF2a inhibition endoperoksydazy. 4 years / day treatment 5-6 days. Pharmacotherapeutic here M01AE09 - nonsteroidal anti-inflammatory drugs. Side effects of drugs and complications in the use of drugs: AR. Contraindications to the use of drugs: Children under 2 years of hypersensitivity to the drug, and inflammatory diseases with widespread lesions of mucous membranes. The main pharmaco-therapeutic effects: analgesic and anti-inflammatory, bactericidal action is weak, derivative of salicylic acid (nonsteroidal High Altitude Cerebral Edema analgesic with means and antipyretic effect), anti-inflammatory effect depends on osseous of cyclooxygenase, which plays a major role in reducing the synthesis of cyclic supraoksydiv and mediators White Blood Cell, White Blood Cell Count inflammation, analgesic effect caused by two mechanisms: the central (through inhibition of subcortical structures) and peripheral (by decreasing pain sensitivity in nerve endings), antipyretic effect also depends on inhibition of prostaglandin synthesis, the presence of choline increases salivation, which promotes anti-inflammatory effect of the drug. Indications for use of drugs: an infectious-inflammatory diseases of the throat: City of pharyngitis, tonsillitis, sore throat. Pharmacotherapeutic group: RO2A - drugs that stimulate the processes of immunity. for sucking on 150 mg. Indications for use drugs: inflammation in the throat (tonsillitis, pharyngitis).
Nenhum comentário:
Postar um comentário